A Multi-centre, Phase 1 / 2, Randomised, Double-blind, Placebo-controlled Study with an Optional Open-label Extension to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics of PLL001 for the Treatment of Subjects with Amyotrophic Lateral Sclerosis.

  • Rodrigues, Joseph (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date2/01/25 → 30/12/26

Keywords

  • Clinical Trials
  • PLL001-101